Can Lifestyle Medicine Finally Get Its Shot in Medicare?

The Centers for Medicare & Medicaid Services (CMS), by way of its Innovation Center, has introduced one of the crucial philosophically formidable fashions within the company’s historical past: Enhancing Lifestyle and Evaluating Value-based Approaches Through Evidence, or MAHA ELEVATE. Backed by roughly $100 million in cooperative settlement funding, the mannequin will check whether or not whole-person practical and life-style medication (FLM) interventions can enhance well being outcomes and scale back prices for Original Medicare beneficiaries (i.e., Parts A and B).

The Notice of Funding Opportunity (NOFO) dropped in March 2026, with a compulsory letter of intent due April 10 and full functions due May 15. The first of two cohorts will launch in October 2026, and as much as 30 awards will probably be distributed throughout each cohorts. Each recipient can obtain as much as $3.3 million over a three-year efficiency interval. Three of these awards are reserved particularly for interventions concentrating on dementia and cognitive decline.

This article examines how the mannequin works, what it calls for of candidates, and why it represents a significant departure from how CMS has traditionally approached persistent illness.

Note: I’m not masking this as a result of I believe the “MAHA movement” itself is definitely able to bettering well being resulting from their false beliefs about which interventions ought to be carried out and their damaging beliefs about vaccines. However, you will need to disentangle the precise insurance policies and their potential influence from the political rhetoric. The MAHA motion will get just a few issues proper, although, together with that we have to take into account life-style habits and diet extra successfully, we have to regulate the meals trade (utilizing evidence-based policymaking), and we must always take main steps to enhance well being in America.

The premise is simple and well-documented. In 2022, roughly 45% of Medicare beneficiaries had four or more chronic conditions, and people beneficiaries accounted for practically 90% of whole well being care spending. The American well being care system stays overwhelmingly reactive: it treats ailments after they develop, manages signs with prescribed drugs and procedures, and invests virtually nothing within the upstream behavioral and environmental components that drive persistent sickness within the first place. I’ve lengthy been an advocate for the usage of medical care funds to maneuver into extra upstream public well being actions. Medicare’s funding dwarfs that of public well being businesses all through the nation.

The proof base for life-style medication’s influence on these circumstances is nice in line with those that write concerning the idea. Bodai et al. (2018), writing in The Permanente Journal, cataloged findings throughout heart problems, sort 2 diabetes, and customary cancers. Their assessment famous that greater than 80% of persistent circumstances may very well be prevented by way of the adoption of wholesome life-style suggestions. A prospective study of 23,000 members they cited discovered that adherence to 4 fundamental behaviors (i.e., no tobacco, common train, sustaining a wholesome weight, and consuming a plant-rich weight-reduction plan) was related to a 78% lowered danger of growing any persistent situation over eight years, a 93% lowered danger of diabetes, an 81% lowered danger of myocardial infarction, and a 36% discount in most cancers danger. Even in sufferers already identified with heart problems, life-style applications incorporating whole-food, plant-based diets have demonstrated the capability to reverse arterial plaque, in line with Bodai and colleagues.

The financial argument is equally stark. Bodai et al. noticed that well being care expenditure within the United States exceeded $3.0 trillion in 2015, with persistent circumstances accounting for 75% or extra of these prices. Despite this spending, outcomes within the U.S. rank among the worst of superior economies.

So if we all know that life-style interventions work, why aren’t they commonplace observe?

A major a part of the reply lies in coaching. Polak, Pojednic, and Phillips (2015), within the American Journal of Lifestyle Medicine, documented that as not too long ago as 2008, solely 27% of U.S. medical colleges supplied the really helpful minimal of 25 hours of diet schooling. Only 30% of well being professionals surveyed reported offering train counseling within the prior 12 months.

The obstacles cited had been predictable: lack of time, compensation, data, and sources. The subject of life-style medication schooling stays nascent, with curriculum improvement throughout undergraduate, graduate, and persevering with medical schooling nonetheless in early levels. The Lifestyle Medicine Education (LMEd) Collaborative was based solely in 2013 to start systematically embedding these competencies into medical faculty coaching.

As is normally the case in well being companies, we now have a problem associated to each financing (i.e., reimbursement or fee coverage) and coaching/operationalization. We don’t have the funding in place to carry out the evidence-based actions, and, after we do, operationalizing them is difficult for almost all of well being care organizations and clinicians.

MAHA ELEVATE doesn’t remedy the coaching hole. But it does one thing that Medicare has by no means finished earlier than: it creates a funded, structured mechanism to generate rigorous value and high quality proof for whole-person FLM interventions within the Original Medicare inhabitants. The proof from this mannequin may finally assist new protection determinations.

MAHA ELEVATE is structured as a cooperative settlement. It isn’t a grant, not a fee mannequin, and never a waiver. This distinction issues. Under a cooperative settlement, CMS maintains substantial programmatic involvement all through the lifetime of the challenge. Recipients ought to anticipate month-to-month calls with a CMS challenge officer, obligatory participation in studying system occasions, and shut collaboration on knowledge assortment protocols, research design, and analysis methodology.

The mannequin is formed partly by the American College of Lifestyle Medicine’s six foundational pillars: diet, bodily exercise, restorative sleep, stress administration, avoidance of dangerous substances, and constructive social connections. Applicants should incorporate both diet or bodily exercise as a core element of their proposed intervention. The remaining pillars are non-compulsory however inspired.

Critically, MAHA ELEVATE is designed to check interventions that complement standard medical care. The cooperative settlement funds could solely be used for companies not presently coated by Original Medicare. Any coated companies delivered as a part of a broader program should be billed to Medicare by way of commonplace channels.

Each applicant will choose a persistent situation (or set of circumstances) to focus on, determine a number of FLM interventions to ship, and recruit Original Medicare beneficiaries into their program. CMS strongly prefers randomized enrollment designs, with some sufferers receiving the FLM intervention and others receiving the traditional commonplace of care. If individual-level randomization isn’t possible, practice- or site-level randomization could also be acceptable. This is a giant deal because it helps generate robust proof if this method works or not.

The minimal variety of beneficiaries required will probably be decided by CMS after utility assessment, primarily based on the proposed intervention’s anticipated impact dimension. Larger pattern sizes strengthen the analysis, so CMS encourages candidates to accomplice with different organizations to increase their attain.

The funding construction is milestone-based and intentionally demanding. Sixty p.c of every award is tied to operational milestones similar to submitting beneficiary rosters on time, reporting medical knowledge, partaking with the analysis contractor, and assembly enrollment thresholds. The remaining 40% is tied to reaching quartile benchmarks for minimal beneficiary targets (25%, 50%, 75%, and 100% of the goal).

The design builds in arduous termination triggers. If a recipient has not begun enrolling sufferers inside 12 months of the award, the settlement could also be terminated. If a recipient fails to succeed in 20% of their beneficiary goal by 20 months, termination is on the desk. At 32 months, the edge rises to 65%.

Awards are disbursed in as much as 9 funds over the three-year interval. A $1.2 million preliminary fee (40% of a $3 million award) is made upon receipt of the Notice of Award, with the remaining operational milestone funds of $150,000 every launched at 14, 20, 26, and 32 months, contingent on demonstrated progress.

This cooperative settlement mannequin is nice because it helps present the cashflow upfront to construct and assist the mannequin versus utilizing a system that reimburses after value is incurred by the delivering group. As is seldom talked about in well being coverage, cashflow is king!

Eligibility is broad. CMS has opened the mannequin to personal medical practices, well being methods, ACOs, tutorial organizations, practical and life-style medication facilities, FQHCs, Rural Health Clinics, community-based organizations, tribal well being applications, state and native governments, and senior dwelling communities. Applicants don’t must be medical entities, however these that aren’t should accomplice with organizations that ship medical care.

Applicants should reveal prior expertise integrating whole-person FLM into standard care with documented enhancements in well being, high quality, and price. They should additionally present peer-reviewed proof supporting the protection and efficacy of the proposed intervention. This isn’t a mannequin for untested concepts, however slightly it’s a mannequin for scaling and rigorously evaluating approaches that have already got a monitor document. This is nice to notice as it’s considerably totally different than the anticipated ACCESS mannequin.

More right here:

Over 15 years, the CMS Innovation Center has examined dozens of different fee fashions: bundled funds, accountable care organizations, major care transformation initiatives, and episode-based pricing. These fashions have overwhelmingly targeted on how care is paid for by aligning monetary incentives, shifting danger, and lowering pointless utilization. MAHA ELEVATE is totally different as a result of it focuses on what care is delivered. This is vital because the wrestle underneath these prior fee experiments is two-fold: there might be gaming of the monetary incentives slightly than actual care enchancment and care supply mannequin change is harder than opting into a brand new fee mannequin which results in failure amongst members.

Most Innovation Center fashions function inside the present Medicare profit construction. They redesign fee flows round coated companies. MAHA ELEVATE goes additional: it funds companies that Medicare doesn’t presently cowl, exactly as a result of the real-world proof base for these companies within the Medicare inhabitants is skinny. The mannequin is designed to generate that proof by way of real-world testing with rigorous analysis, together with randomized controls, patient-level medical knowledge assortment, and formal value evaluation by CMS’s analysis contractor.

This additionally units MAHA ELEVATE other than prior CMS experiments with persistent illness administration. Models like Comprehensive Primary Care Plus (CPC+) and the ACO REACH mannequin targeted on care coordination, observe transformation, and whole value of care accountability. They operated inside the standard biomedical paradigm (i.e., higher managing sufferers who’re already sick). MAHA ELEVATE asks a extra elementary query: can we intervene upstream, utilizing evidence-based behavioral and dietary approaches, to sluggish or stop the persistent illness trajectory earlier than it consumes the Medicare program (to some extent it already has) and affected person lives?

The cooperative settlement construction additionally distinguishes MAHA ELEVATE from typical Innovation Center fee fashions, which normally function by way of waivers of Medicare fee guidelines. Here, CMS is making direct federal investments in program implementation and analysis, with intensive monitoring, technical help, and collaborative oversight. This is nearer in construction to a analysis program than a fee reform, which is, the fitting option to do this kind of mannequin.

The mannequin isn’t with out challenges. The requirement for revealed, peer-reviewed proof supporting the proposed intervention creates a significant barrier to entry, notably for smaller organizations and rising approaches if CMS requires the proof to be generated from the participant’s applications themselves versus drawing from the broader literature. The milestone-based funding construction, whereas guaranteeing accountability, could penalize applications that serve harder-to-reach populations or goal circumstances with longer intervention timelines.

There are additionally structural tensions. Cooperative settlement funds can’t be used for meals, meals, or meals vouchers though diet is likely one of the two required intervention domains. Applicants can use different funding sources for food-related program parts, however this limitation creates a niche which will constrain program design.

Finally, the mannequin’s three-year timeline is formidable for circumstances which will take years to reveal significant value discount. Diabetes, heart problems, and dementia are slow-moving circumstances. A program could demonstrably enhance medical measures (HbA1c, blood stress, waist circumference) inside three years whereas the downstream value financial savings take longer to materialize in claims knowledge.

MAHA ELEVATE represents the primary time the CMS Innovation Center has created a devoted funding mechanism to check whole-person life-style medication approaches in Original Medicare. It acknowledges what the proof has been saying for many years: that persistent illness is essentially the product of modifiable behaviors, and that addressing these behaviors can produce medical outcomes that rival or exceed pharmacologic interventions — typically at a fraction of the associated fee and with out the negative effects.

The letter of intent deadline is April 10, 2026. Applications are due May 15, 2026, by way of Grants.gov.